Docking and 3-D QSAR Studies on Indolyl Aryl Sulfones. Binding Mode Exploration at the HIV-1 Reverse Transcriptase Non-Nucleoside Binding Site and Design of Highly Active N-(2-Hydroxyethyl)carboxamide and N-(2-Hydroxyethyl)carbohydrazide Derivatives

Autor: Ragno, R., Artico, M., Martino, G. De, Regina, G. La, Coluccia, A., Pasquali, A. Di, Silvestri, R.

Publikováno v: Journal of Medicinal Chemistry; January 2005, Vol. 48 Issue: 1 p213-223, 11p

Simple, Short Peptide Derivatives of a Sulfonylindolecarboxamide (L-737,126) Active in Vitro against HIV-1 Wild Type and Variants Carrying Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations

Autor: Silvestri, R., Artico, M., Martino, G. De, Regina, G. La, Loddo, R., Colla, M. La, Colla, P. La

Publikováno v: Journal of Medicinal Chemistry; July 2004, Vol. 47 Issue: 15 p3892-3896, 5p

Simple, Potent, and Selective Pyrrole Inhibitors of Monoamine Oxidase Types A and B

Autor: Silvestri, R., Regina, G. La, Martino, G. De, Artico, M., Befani, O., Palumbo, M., Agostinelli, E., Turini, P.

Publikováno v: Journal of Medicinal Chemistry; March 2003, Vol. 46 Issue: 6 p917-920, 4p

Three dimensional polyurethane/ hydroxyapatite bioactive scaffolds: The role of hydroxyapatite on pore generation.

Autor: Nasrollah, Seyyed Ahmad Seyyed, Najmoddin, Najmeh, Mohammadi, Mohsen, Fayyaz, Abdolali, Nyström, Bo

Publikováno v: Journal of Applied Polymer Science; 3/15/2021, Vol. 138 Issue 11, p1-14, 14p

A novel allosteric modulator of the cannabinoid CB 1 receptor ameliorates hyperdopaminergia endophenotypes in rodent models.

Autor: Mielnik CA; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Sugamori KS; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Finlay DB; University of Otago, Department of Pharmacology & Toxicology, Dunedin, New Zealand., Thorpe HHA; University of Guelph, Department of Biomedical Sciences, Guelph, ON, Canada., Schapira M; Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada., Sivananthan N; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Li CK; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Lam VM; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Harrington S; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Abdelrahman MH; University of Aberdeen, Aberdeen, UK., Trembleau LA; University of Aberdeen, Aberdeen, UK., McIntyre Burnham W; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Khokhar JY; University of Guelph, Department of Biomedical Sciences, Guelph, ON, Canada., Salahpour A; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Ramsey AJ; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada., Glass M; University of Otago, Department of Pharmacology & Toxicology, Dunedin, New Zealand., Greig IR; University of Aberdeen, Aberdeen, UK., Ross RA; University of Toronto, Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada. ruth.ross@utoronto.ca.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2021 Jan; Vol. 46 (2), pp. 413-422. Date of Electronic Publication: 2020 Oct 08.